<html>
<head>PUBMED IDs for PCPH</head>
<body bgcolor='#C5F0F2'><h1>PCPH</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9767715/'>A genomically modified marker strain of Escherichia coli.</a> October 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10708485/'>The human PCPH proto-oncogene: cDNA identification, primary structure, chromosomal mapping, and expression in normal and tumor cells.</a> March 9  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10749145/'>Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1.</a> April 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11121232/'>Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines.</a> December 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11933075/'>Deregulated expression of the PCPH proto-oncogene in rat mammary tumors induced with 7,12-dimethylbenz[a]anthracene.</a> April 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12489110/'>Gradual deregulation and loss of PCPH expression in the progression of human laryngeal neoplasia.</a> December 19  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14559816/'>The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation.</a> October 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15375529/'>Deregulated expression of the PCPH proto-oncogene in human breast cancers.</a> September 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16465363/'>PCPH expression is an early event in the development of testicular germ cell tumors.</a> February 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18006831/'>PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism.</a> November 17  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19176496/'>Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest.</a> July 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/24094823/'>A pH-sensitive gene delivery system based on folic acid-PEG-chitosan - PAMAM-plasmid DNA complexes for cancer cell targeting.</a> May 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25045656/'>NTPDase5/PCPH as a new target in highly aggressive tumors: a systematic review.</a> March 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26869785/'>A novel type of self-assembled nanoparticles as targeted gene carriers: an application for plasmid DNA and antimicroRNA oligonucleotide delivery.</a> August 31  2016<br></body></html>
